HB2248: Substance use disorder; providers of treatment, use of methadone or opioid replacements.

Legislative Summary

Providers of treatment for substance use disorder; use of methadone or opioid replacements; biometric certification. Requires providers of treatment for substance use disorder who administer methadone or opioid replacements as treatments to utilize biometric certification to verify the identity of the clinician and patient. Biometric certification includes iris scans of patients and either iris scans or two-finger fingerprint scans of clinicians. The bill requires the Board of Pharmacy to establish a statewide data repository for the storage of records of every transaction involving the administration of methadone or opioid replacements to a patient, with such records being held for no fewer than 10 years.